Suppr超能文献

特立帕肽治疗对绝经后骨质疏松症患者内皮功能、糖代谢及炎症标志物的影响

Effect of teriparatide treatment on endothelial function, glucose metabolism and inflammation markers in patients with postmenopausal osteoporosis.

作者信息

Celer Ozgen, Akalın Aysen, Oztunali Cigdem

机构信息

Department of Endocrinology and Metabolism, Eskisehir Osmangazi University, Eskisehir, Turkey.

Department of Radiology, Eskisehir Osmangazi University, Eskisehir, Turkey.

出版信息

Clin Endocrinol (Oxf). 2016 Oct;85(4):556-60. doi: 10.1111/cen.13139. Epub 2016 Jul 19.

Abstract

OBJECTIVE

Teriparatide, an anabolic agent used in the treatment of postmenopausal osteoporosis, can induce effects similar to primary hyperparathyroidism. Our objective was to evaluate the effects of teriparatide on endothelial functions, glucose metabolism and inflammation markers in patients diagnosed with postmenopausal osteoporosis.

DESIGN, PATIENTS AND MEASUREMENTS: This was a single-centre, single-arm, 6-month prospective study. Twenty-three postmenopausal women over 65 years old with a lumbar spine or femoral neck T-score of -4·0 or lower and having at least two compression fractures in thoracic or lumbar spine were studied. Low-dose intermittent teriparatide (20 μg/day) was supplemented with calcium carbonate (1000 mg elemental calcium) and 880 IU cholecalciferol for 6 months. The biochemical parameters for glucose metabolism, inflammation and atherosclerosis were determined. For the assessment of vascular endothelial function, carotid intima-media thickness (CIMT), brachial artery intima-media thickness (BIMT), per cent change in flow-mediated dilation (FMD%) and nitroglycerine-induced dilations (NID%) were measured on ultrasonography.

RESULTS

The fasting plasma glucose, homoeostatic model assessment of insulin resistance, fibrinogen, homocysteine and high-density lipoprotein cholesterol increased significantly with teriparatide treatment (P < 0·05 for all). Baseline CIMT and BIMT did not change significantly with 6 months of teriparatide treatment (P > 0·05); however, FMD% and NID% showed significant decrease after treatment (P < 0·01 for both).

CONCLUSIONS

Intermittent teriparatide treatment may adversely affect some parameters of glucose metabolism, inflammation and endothelial function. On the basis of our findings, further large-scale and controlled studies are needed to clarify the exact effect of teriparatide treatment on glucose metabolism, inflammation and endothelial function.

摘要

目的

特立帕肽是一种用于治疗绝经后骨质疏松症的促合成代谢药物,可诱发类似于原发性甲状旁腺功能亢进的效应。我们的目的是评估特立帕肽对诊断为绝经后骨质疏松症患者的内皮功能、糖代谢和炎症标志物的影响。

设计、患者与测量:这是一项单中心、单臂、为期6个月的前瞻性研究。研究了23名65岁以上的绝经后女性,她们的腰椎或股骨颈T值为-4.0或更低,且在胸椎或腰椎至少有两处压缩性骨折。低剂量间歇性特立帕肽(20μg/天)与碳酸钙(1000mg元素钙)和880IU胆钙化醇一起补充6个月。测定了糖代谢、炎症和动脉粥样硬化的生化参数。为评估血管内皮功能,通过超声测量颈动脉内膜中层厚度(CIMT)、肱动脉内膜中层厚度(BIMT)、血流介导的扩张百分比(FMD%)和硝酸甘油诱导的扩张(NID%)。

结果

特立帕肽治疗后,空腹血糖、胰岛素抵抗稳态模型评估、纤维蛋白原、同型半胱氨酸和高密度脂蛋白胆固醇显著升高(所有P<0.05)。特立帕肽治疗6个月后,基线CIMT和BIMT无显著变化(P>0.05);然而,治疗后FMD%和NID%显著降低(两者均P<0.01)。

结论

间歇性特立帕肽治疗可能对糖代谢、炎症和内皮功能的某些参数产生不利影响。根据我们的研究结果,需要进一步进行大规模对照研究,以阐明特立帕肽治疗对糖代谢、炎症和内皮功能的确切影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验